vTv has a proprietary drug discovery engine called TTP Translational Technology, and is focused on developing drug candidates for the treatment of a wide range of human diseases.

The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts.

The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.